Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Company dna tibotec virco virology bvba
no operation time available
2 offices
active in Legal Services

We have observed 13 EP applications Eva van Wanrooij has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after April 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13700017

4,4-DISUBSTITUTED-1,4-DIHYDROPYRIMIDINES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
A61K 31/506, A61K 31/527, A61P 31/20, C07D 239/22, C07D 401/04, C07D 403/04, C07D 417/04, C07D 471/10, C07D 491/107
Applicant:
Janssen Research & Development Ireland
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13727080

URACYL SPIROOXETANE NUCLEOSIDES

IPC classification:
A61K 31/7072, A61P 31/14, C07H 19/11
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
PATENT GRANTED
EP13756109

FUSED BICYCLIC SULFAMOYL DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
A61K 31/416, A61K 31/42, C07D 231/56, C07D 261/20
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
PATENT GRANTED
EP13756110

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
A61K 31/18, A61K 31/277, A61K 31/337, A61K 31/341, A61K 31/351, A61K 31/381, A61K 31/4164, A61K 31/4453, A61P 1/18, A61P 31/20, C07C 311/37, C07D 231/14, C07D 295/26, C07D 309/14, C07D 333/46
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
EXAMINATION IN PROGRESS
EP13756113

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
A61K 31/18, A61K 31/337, A61K 31/341, A61K 31/351, A61K 31/4164, A61K 31/426, A61K 31/44, A61K 31/4453, A61K 31/4468, A61P 31/20, C07C 311/16, C07C 311/20, C07C 311/51, C07D 233/42, C07D 277/16, C07D 309/14
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
GRANT OF PATENT INTENDED
EP14707372

SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
A61K 31/18, A61P 31/20, C07C 311/16
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
PATENT GRANTED
EP14714292

N-PHENYL-CARBOXAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
C07D 207/16, C07D 209/42, C07D 405/12, C07D 409/12, C07D 487/08
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
The patent has been granted
EP11727184

PREPARATION OF 13-CYCLOHEXYL-3-METHOXY-6-[METHYL-(2-{2-[METHYL-(SULPHAMOYL)-AMINO]-ETHOXY}-ETHYL)-CARBAMOYL]-7H-INDOLO-[2,1-a]-[2]-BENZAZEPINE-10-CARBOXYLIC ACID

IPC classification:
C07C 307/06, C07D 223/14, C07D 487/04
Applicant:
Janssen Research & Development Ireland
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14727752

SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
A61K 31/401, A61P 31/00, C07D 207/40
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
GRANT OF PATENT INTENDED
EP11785634

URACYL SPIROOXETANE NUCLEOSIDE PHOSPHORAMIDATES

IPC classification:
A61K 31/7072, A61P 31/14, C07H 19/06
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11740622

HETERO-BICYCLIC DERIVATIVES AS HCV INHIBITORS

IPC classification:
A61K 31/47, A61K 31/4704, A61P 31/12, C07D 401/14, C07D 403/14, C07D 417/14, C07D 471/04, C07D 491/10
Applicant:
Janssen Research & Development Ireland
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11781797

URACYL SPIROOXETANE NUCLEOSIDE PHOSPHORAMIDATES

IPC classification:
A61K 31/7072, A61P 31/14, C07H 19/06
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
PATENT GRANTED
EP15704502

SULPHAMOYLPYRROLAMIDE DERIVATIVES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B

IPC classification:
C07D 401/12, C07D 405/14
Applicant:
Janssen Sciences Ireland UC
Agent:
Eva van Wanrooij, J&J Patent Law Department
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature